Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Headline from NBC4 Washington
Moderna said its combination vaccine targeting Covid and the flu was more effective than existing standalone shots for those viruses in a late-stage trial.
NBC4 Washington's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Moderna said its combination vaccine targeting Covid and the flu was more effective than existing standalone shots for those viruses in a late-stage trial.
Moderna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3 clinical trials, mRNA-1083 achieved a better immune response than other vaccines.
Moderna's combination flu and COVID-19 vaccine is more effective in preventing disease than a separate shot of each type, according to new clinical trial data.
Moderna said on Monday its combination vaccine to protect against both Covid and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against the viruses in a late-stage trial.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial | Since Then